Developer docs
API playgroundTry for free, no card

Search company profiles

Caricord

Full company profile

uuid003iaor

Namestring
Caricord
Legal namestring
Lifebank
Websiteurl
caricord.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Caricord, operating under the brand "Lifebank By Celularity," is a privately held cord blood and placental tissue banking service headquartered in Cedar Knolls, New Jersey, with an additional office in Florham Park, New Jersey. The company preserves hematopoietic stem cells (HSCs) extracted from umbilical cord blood — FDA-approved for treatment of 80+ diseases — and mesenchymal stem cells (MSCs) extracted from placental tissue, which have applications in regenerative medicine including skeletal tissue repair. Processing and storage operate through a strategic affiliation with Celularity, a biotechnology company focused on placental-derived stem cell therapies that provides the underlying scientific and technical infrastructure.

Lifebank serves expectant parents and families through a direct-to-consumer model. Customers enroll online, schedule planning sessions, and have stem cell collections picked up by medical couriers immediately after birth. The product portfolio includes cord blood banking, placental banking, a combined Cord + Placental Tissue package, a Sibling Program offering discounted services for families with an existing child who may benefit from a stored match, and a public Donation Program for altruistic contribution to other patients. The company markets through its website, educational content, scheduled planning sessions, and earned media coverage in outlets including Fox Business, NBC, CBS, Wall Street Journal, Science AAAS, New York Times, and Life Science Leader.

The revenue model is subscription-based with annual recurring billing for long-term cryogenic storage of stem cell collections. Pricing tiers are available on the company's website but are not detailed in the source material. As a subsidiary of Celularity, Lifebank's strategic positioning is closely tied to its parent's broader cell therapy platform, which provides both scientific credibility and operational infrastructure.

Short descriptiontext

Caricord (Lifebank by Celularity) is a direct-to-consumer cord blood and placental tissue banking service that preserves newborn stem cells using patented processing methods, serving expectant families through subscription-based long-term storage.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, placental tissue storage, stem cell preservation, newborn family banking, mesenchymal cell storage
Industry1 code
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Stem Cell Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cord Blood Banking
TypeSubscription Recurring
Description

Storage of umbilical cord blood containing hematopoietic stem cells (HSCs) for future medical treatments. FDA-approved to treat more than 80 diseases.

lifebankusa.com
2Placental Banking
TypeSubscription Recurring
Description

Storage of placental tissue containing mesenchymal stem cells (MSCs) with potential applications in regenerative medicine for skeletal tissue repair.

lifebankusa.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Pricing details1 tier
1Pricing & Packages available on website
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing and package details available at lifebankusa.com/prices-packages/ - specific tiers not detailed in source content

lifebankusa.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Caricord markets family stem cell banking services that preserve umbilical cord blood and placental tissue after birth, using patented processing methods through the Lifebank By Celularity™ brand. Core offerings include cord blood banking (HSCs for cellular therapies, FDA-approved for 80+ diseases), placental banking (MSCs for regenerative medicine), combined cord and placental packages, a sibling discount program, and a public donation program. Customers enroll online, schedule planning sessions, and rely on a medical courier to collect the sample at birth.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Lifebank By Celularity™ (Caricord) operates as a unified cord blood and placental banking platform offering stem cell preservation services. The core product portfolio centers on cord blood banking (preserving hematopoietic stem cells for cellular therapies) and placental banking (preserving mesenchymal stem cells for regenerative medicine). Additional offerings include combined cord and placental tissue packages, a sibling discount program, and a public donation program. The company utilizes proprietary patented processing methods and is operated by Celularity.

Product and service5 records
1Cord Blood Banking
CategoryCord Blood Banking
Description

Umbilical cord blood banking service that preserves hematopoietic stem cells (HSCs) for cellular therapies; marketed to expectant parents. Cord blood stem cells are FDA-approved to treat more than 80 diseases.

2Placental Banking
CategoryPlacental Tissue Banking
Description

Preservation service for placental tissue and placental blood containing mesenchymal stem cells (MSCs) and hematopoietic stem cells, with potential applications in regenerative medicine including bone, cartilage, and fat tissue repair; marketed to expectant parents.

3Cord + Placental Tissue Package
CategoryCombined Stem Cell Banking
Description

Combined banking package that preserves both umbilical cord blood (HSCs) and placental tissue (MSCs) for families seeking comprehensive stem cell preservation; sold as a single offering.

4Sibling Program
CategoryFamily Banking Program
Description

Discounted cord blood banking program for families with an existing child who may benefit from stored stem cells, enabling biological-sibling stem cell compatibility use cases.

5Donation Program
CategoryPublic Stem Cell Donation
Description

Public donation program allowing families to donate cord blood and placental stem cells for use by unrelated patients in need, supporting the broader public stem cell supply.

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Lifebank operates as 'Lifebank By Celularity' using Celularity's processing and storage facilities. The partnership leverages Celularity's cell therapy platform and proprietary processing methods for stem cell banking services. Video content references 'Lifebank's patented processing methods' and 'Celularity Virtual Tour' showing inside look at processing and storage operations.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest U.S. private cord blood bank offering cord blood and cord tissue storage with a direct-to-consumer model targeting expectant parents — directly comparable to Lifebank's core banking proposition.

TypeDirect peer
Description

Private family cord blood and cord tissue bank (owned by Sema4 / formerly PerkinElmer) offering subscription storage with direct-to-consumer acquisition — overlapping product set and customer base with Lifebank.

TypeBroad incumbent
Description

Lifesbank's parent company and broader placental-derived cell therapy and biologics platform — comparable in tissue/cell processing technology but operating at the biotech platform level rather than consumer banking.

TypeDirect peer
Description

U.S. private cord blood and tissue bank with direct-to-consumer enrollment and annual storage fees — same niche consumer-services revenue model.

TypeOthers
Description

Supplier of cryopreservation media and cold-chain tools used by cell and tissue banks including cord blood banks — ecosystem participant rather than competitor, but operationally linked to Lifebank's storage process.

TypeDirect peer
Description

Private cord blood, cord tissue, and placenta blood bank selling directly to expectant parents with annual storage plans — same category, same buyer, similar premium positioning.

TypeOthers
Description

Provider of temperature-controlled logistics for life sciences, including stem cell and reproductive medicine shipments — analogous 'last-mile cold chain' role to Lifebank's medical courier pickup model.

TypeDirect peer
Description

Hybrid public/private cord blood bank offering family banking alongside public donation programs — comparable product mix including donation SKUs similar to Lifebank's donation module.

TypeDirect peer
Description

Cord blood banking service operated by Maze Laboratories, targeting expectant parents with subscription storage — direct overlap in product, customer segment, and go-to-market motion.

TypeDirect peer
Description

Publicly traded cord blood bank offering private cord blood and menstrual stem cell banking with annual storage fees — comparable business model, recurring revenue structure, and DTC funnel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Caricord

Stem Cell Banking Servicescaricord.com

Caricord (Lifebank by Celularity) is a direct-to-consumer cord blood and placental tissue banking service that preserves newborn stem cells using patented processing methods, serving expectant families through subscription-based long-term storage.

What Caricord does

Caricord, operating under the brand "Lifebank By Celularity," is a privately held cord blood and placental tissue banking service headquartered in Cedar Knolls, New Jersey, with an additional office in Florham Park, New Jersey. The company preserves hematopoietic stem cells (HSCs) extracted from umbilical cord blood — FDA-approved for treatment of 80+ diseases — and mesenchymal stem cells (MSCs) extracted from placental tissue, which have applications in regenerative medicine including skeletal tissue repair. Processing and storage operate through a strategic affiliation with Celularity, a biotechnology company focused on placental-derived stem cell therapies that provides the underlying scientific and technical infrastructure.

Lifebank serves expectant parents and families through a direct-to-consumer model. Customers enroll online, schedule planning sessions, and have stem cell collections picked up by medical couriers immediately after birth. The product portfolio includes cord blood banking, placental banking, a combined Cord + Placental Tissue package, a Sibling Program offering discounted services for families with an existing child who may benefit from a stored match, and a public Donation Program for altruistic contribution to other patients. The company markets through its website, educational content, scheduled planning sessions, and earned media coverage in outlets including Fox Business, NBC, CBS, Wall Street Journal, Science AAAS, New York Times, and Life Science Leader.

The revenue model is subscription-based with annual recurring billing for long-term cryogenic storage of stem cell collections. Pricing tiers are available on the company's website but are not detailed in the source material. As a subsidiary of Celularity, Lifebank's strategic positioning is closely tied to its parent's broader cell therapy platform, which provides both scientific credibility and operational infrastructure.

Caricord firmographics

Firmographics
Name
Caricord
Legal name
Lifebank
Website
https://caricord.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Caricord (Lifebank by Celularity) is a direct-to-consumer cord blood and placental tissue banking service that preserves newborn stem cells using patented processing methods, serving expectant families through subscription-based long-term storage.
Ownership category
akta.pro rank

Caricord industry classification

Industry
Product category
Stem Cell Banking Services
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Cord blood banking
  • Placental tissue storage
  • Stem cell preservation
  • Newborn family banking
  • Mesenchymal cell storage

Where Caricord is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Caricord business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Cord Blood Banking: Storage of umbilical cord blood containing hematopoietic stem cells (HSCs) for future medical treatments. FDA-approved to treat more than 80 diseases.
  2. Placental Banking: Storage of placental tissue containing mesenchymal stem cells (MSCs) with potential applications in regenerative medicine for skeletal tissue repair.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPricing & Packages available on website

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Caricord product offering

Product offering

Core offering

Caricord markets family stem cell banking services that preserve umbilical cord blood and placental tissue after birth, using patented processing methods through the Lifebank By Celularity™ brand. Core offerings include cord blood banking (HSCs for cellular therapies, FDA-approved for 80+ diseases), placental banking (MSCs for regenerative medicine), combined cord and placental packages, a sibling discount program, and a public donation program. Customers enroll online, schedule planning sessions, and rely on a medical courier to collect the sample at birth.

Product overview

Lifebank By Celularity™ (Caricord) operates as a unified cord blood and placental banking platform offering stem cell preservation services. The core product portfolio centers on cord blood banking (preserving hematopoietic stem cells for cellular therapies) and placental banking (preserving mesenchymal stem cells for regenerative medicine). Additional offerings include combined cord and placental tissue packages, a sibling discount program, and a public donation program. The company utilizes proprietary patented processing methods and is operated by Celularity.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cord Blood Banking Umbilical cord blood banking service that preserves hematopoietic stem cells (HSCs) for cellular therapies; marketed to expectant parents. Cord blood stem cells are FDA-approved to treat more than 80 diseases.
  • Placental Banking Preservation service for placental tissue and placental blood containing mesenchymal stem cells (MSCs) and hematopoietic stem cells, with potential applications in regenerative medicine including bone, cartilage, and fat tissue repair; marketed to expectant parents.
  • Cord + Placental Tissue Package Combined banking package that preserves both umbilical cord blood (HSCs) and placental tissue (MSCs) for families seeking comprehensive stem cell preservation; sold as a single offering.
  • Sibling Program Discounted cord blood banking program for families with an existing child who may benefit from stored stem cells, enabling biological-sibling stem cell compatibility use cases.
  • Donation Program Public donation program allowing families to donate cord blood and placental stem cells for use by unrelated patients in need, supporting the broader public stem cell supply.

Companies that use Caricord

Customer profile

Segments1 record

Ideal customer profiles1 record

Caricord technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Caricord partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CelularitycoreTechnology or IntegrationLifebank operates as 'Lifebank By Celularity' using Celularity's processing and storage facilities. The partnership leverages Celularity's cell therapy platform and proprietary processing methods for stem cell banking services. Video content references 'Lifebank's patented processing methods' and 'Celularity Virtual Tour' showing inside look at processing and storage operations.

Recent moves5 records

Expansion highlights4 records

Caricord competitors and assessment

Company assessment

Direct peers

  • Cord Blood Registry (CBR): Largest U.S. private cord blood bank offering cord blood and cord tissue storage with a direct-to-consumer model targeting expectant parents — directly comparable to Lifebank's core banking proposition.
  • ViaCord: Private family cord blood and cord tissue bank (owned by Sema4 / formerly PerkinElmer) offering subscription storage with direct-to-consumer acquisition — overlapping product set and customer base with Lifebank.
  • AlphaCord: U.S. private cord blood and tissue bank with direct-to-consumer enrollment and annual storage fees — same niche consumer-services revenue model.
  • Americord Registry: Private cord blood, cord tissue, and placenta blood bank selling directly to expectant parents with annual storage plans — same category, same buyer, similar premium positioning.
  • StemCyte: Hybrid public/private cord blood bank offering family banking alongside public donation programs — comparable product mix including donation SKUs similar to Lifebank's donation module.
  • Maze Cord Blood Bank: Cord blood banking service operated by Maze Laboratories, targeting expectant parents with subscription storage — direct overlap in product, customer segment, and go-to-market motion.
  • Cryo-Cell International: Publicly traded cord blood bank offering private cord blood and menstrual stem cell banking with annual storage fees — comparable business model, recurring revenue structure, and DTC funnel.

Broad incumbents

  • Celularity: Lifesbank's parent company and broader placental-derived cell therapy and biologics platform — comparable in tissue/cell processing technology but operating at the biotech platform level rather than consumer banking.

Others

  • BioLife Solutions: Supplier of cryopreservation media and cold-chain tools used by cell and tissue banks including cord blood banks — ecosystem participant rather than competitor, but operationally linked to Lifebank's storage process.
  • Cryoport Systems: Provider of temperature-controlled logistics for life sciences, including stem cell and reproductive medicine shipments — analogous 'last-mile cold chain' role to Lifebank's medical courier pickup model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Caricord social profiles

Digital presence

Caricord financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Caricord leadership team

Management profile

Number of profiles

Caricord funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Caricord M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caricord

What does Caricord do?

Caricord markets family stem cell banking services that preserve umbilical cord blood and placental tissue after birth, using patented processing methods through the Lifebank By Celularity™ brand. Core offerings include cord blood banking (HSCs for cellular therapies, FDA-approved for 80+ diseases), placental banking (MSCs for regenerative medicine), combined cord and placental packages, a sibling discount program, and a public donation program. Customers enroll online, schedule planning sessions, and rely on a medical courier to collect the sample at birth.

Is Caricord a public or private company?

Caricord is a private company. It is classified as corporate owned and is currently operating.

When was Caricord founded?

Caricord was founded in 2013. It employs 1 to 10 people.

Where is Caricord based?

Caricord is headquartered in Irvine, United States, in the North America region.

How does Caricord make money?

Two revenue lines are on record. Cord Blood Banking is the primary driver. The others are placental Banking.

Who are Caricord's main competitors?

Direct peers on record are Cord Blood Registry (CBR), ViaCord, AlphaCord, Americord Registry, StemCyte, Maze Cord Blood Bank and Cryo-Cell International. Celularity is listed as a broad incumbent. Others are BioLife Solutions and Cryoport Systems.

Does Caricord have an API?

No public API is recorded for Caricord.

What industry is Caricord in?

Caricord's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals